Quick Listen: Scrip’s Five Must-Know Things
Coronavirus Vaccine Progress, A New CAR-T And A Big Oncology Deal
Executive Summary
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.
Take a brief audio tour around Scrip’s Five Must-Know Things, in this episode covering major industry developments in the business week ended 31 July 2020.
Further progress with multiple coronavirus vaccines, a new CAR-T therapy in the US, and a breakdown of a huge new oncology deal are covered this week.
Stories mentioned in this episode:
(Also see "Can An Antibody Cocktail Block COVID-19 Infection? Regeneron’s Warp Speed Research Aims To Find Out Soon" - Scrip, 27 Jul, 2020.)
(Also see "China Advances Two Coronavirus Vaccines Into Phase III" - Scrip, 28 Jul, 2020.)
(Also see "Pfizer Lays Out Multi-Phase COVID-19 Vaccine Commercial Strategy" - Scrip, 28 Jul, 2020.)
(Also see "Gilead/Kite Gain Second CAR-T Approval With Tecartus, Price On Par With Their First" - Scrip, 26 Jul, 2020.)
(Also see "Oncology Deal-Making The Daiichi Way" - Scrip, 27 Jul, 2020.)